-
Study aim
-
effect of dexmedetomidine(DEX) on postoperative nausea & vomiting(ponv) in laparoscopic cholecystectomy in addicted patients
-
Design
-
Clinical trial with control group, parallel groups, double-blind, randomized, phase 3 on 100 patients, patients with aspect ratio (1:1), receiving DEX or placebo, according to the random number generation table
-
Settings and conduct
-
100 addicted patients, laparoscopic cholecystectomy ,Shohadaye Tajrish Hosp, written consent, by random block division into 2 groups of 50 people (intervention and placebo group), DEX and placebo with shape, color, size and same packaging, A&B coding before use (not by researcher),10 minutes after induction until the end , intervention group under infusion of of DEX and placebo group under infusion of normal saline, recording information during and after operation by an experienced person (unfamiliar with the control & intervention groups), transfer to the recovery, observation and interview by trained personnel to evaluate variables (nausea,retching, vomiting, regurgitation), recording data in different minutes, making 2 files (intervention & control groups) for statistical use
-
Participants/Inclusion and exclusion criteria
-
Inclusion :
Addicted ,age 20 - 60 , ASA 1& 2, SBP before & during operation between 90 - 140 mm Hg
Exclusion :
Laparotomy, surgery more than 4 hours, severe bleeding, ASA 3, motion sickness ,PONV, heart or GI disease, nausea & vomiting before surgery, drug withdrawal before surgery, anti-emetic drug use
-
Intervention groups
-
10 minutes after induction until the end, intervention group will undergo infusion of 1 microgram per minute DEX per kilogram of weight, placebo group will undergo N/S infusion
-
Main outcome variables
-
degrees of ponv (nausea,retcging,regurgitation ,vomiting) for intervention and control groups, main variable ponv, its degrees ,hemodynamic and demographic variables are secondary.